Novavax (NVAX) Stock Price
$7.99 0%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
2 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Novavax, AI stock picks, stock alerts and much more.
NVAX AI Stock Analysis
AI stock analysis for NVAX is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Novavax (NVAX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Novavax (NVAX) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novavax (NVAX), currently trading at $7.99, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NVAX
-
Novavax, Inc.
-
Symbol
NVAX
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
1.3B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
NVAX Alternative Data
Web Traffic
Novavax receives an estimated 45328 monthly visitors to novavax.com.
-
Web Traffic
45328
-
Change from Previous Month
2.4%
-
3 Month Change
6.8%
-
YoY Change
6.8%
News Mentions
Novavax was mentioned 2 times in the news yesterday.
-
News Mentions
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
100%
Reddit Mentions
Novavax has been mentioned an estimated 1 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
1
-
Daily Change
0%
Twitter Followers
Novavax has 60,988 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
60988
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.1%
-
YoY Change
1.1%
Facebook Engagement
Novavax has engaged 11 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
11
-
Daily Change
21.4%
-
1 Month Change
15.4%
-
3 Month Change
99.6%
-
YoY Change
99.6%
Youtube Subscribers
Novavax has 1,130 subscribers on its main Youtube channel, down by -0.9% over the last month.
-
Youtube Subscribers
1130
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
0.9%
-
YoY Change
0.9%
LinkedIn Followers
72,348 are following Novavax on LinkedIn, up by 0.5% over the last month.
-
LinkedIn Followers
72348
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
1.7%
Job Postings
Novavax has an estimated 7 open job postings, which is down -22.2% over the last month.
-
Job Postings
7
-
Daily Change
22.2%
-
1 Month Change
22.2%
-
3 Month Change
40%
-
YoY Change
40%
LinkedIn Employees
According to LinkedIn, Novavax has 1,179 employees, down by -1% over the last month.
-
LinkedIn Employees
1179
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
16.5%
-
YoY Change
16.5%
Business Outlook
-
Business Outlook
19
-
Change from Previous Month
9.5%
-
3 Month Change
0%
-
YoY Change
0%
NVAX Financials
NVAX Key Metrics
-
Total Revenue
$84.5M
-
Net Income
-$121.3M
-
Earnings per Share
-$0.76
-
Free cash flow
-$145.6M
-
EBITDA
-$105.4M
-
EBITDA Ratio
-1.24711
-
Total Assets
$1.7B
NVAX 2-year Revenue & Income
NVAX 2-year Free Cash Flow
NVAX Technicals
NVAX SMA
NVAX RSI
FAQ
What's the current price of Novavax (NVAX) Stock?
The price of an Novavax (NVAX) share is $7.99.
What's the market cap of Novavax?
The current market cap of Novavax is 1.3B.
Should I buy or sell NVAX?
Novavax exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Novavax a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Novavax stock. There are several bearish signals and market challenges that could negatively impact Novavax's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Novavax (NVAX) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Novavax stock right now, as the outlook appears bearish.
What are some stocks similar to Novavax (NVAX) that investors often compare it to?
Novavax (NVAX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Novavax's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novavax's stock price to be around $7.28 in 2026. Starting from the current price of $7.99, this represents a 8.9% change in price, indicating a bearish outlook for the stock.
How to buy Novavax (NVAX) Stock?
Novavax stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novavax shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.